Efficacy of extremely low-dose rituximab for primary refractory nephrotic syndrome and its influence on renal function, immunoglobulin and Toll-like receptors
ObjectiveTo explore the efficacy of extremely low-dose rituximab for primary refractory nephrotic syndrome and examine its influence on renal function, immunoglobulins and Toll-like receptors (TLRs).MethodsFrom March 2017 to February 2020, 72 patients with primary refractory nephrotic syndrome were...
Saved in:
| Main Authors: | Huang Min, Wang Xiao-xia, Wang Xiao-chun, Wang Qiang |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2022-10-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.10.006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab in the treatment of refractory nephrotic syndrome with massive pleural effusion: one case report
by: Zhang Shuo-fan, et al.
Published: (2021-01-01) -
Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study
by: Aikeda Yimamuyushan, et al.
Published: (2024-12-01) -
Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
by: Xiaoyan Ma, et al.
Published: (2023-12-01) -
A meta-analysis of the efficacy of rituximab in the treatment of refractory nephrotic syndrome
by: Liu Wu, et al.
Published: (2021-01-01) -
Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01)